Ref ID: 18467
Author:
Florentine Marx, Andrea Eigentler, Ulrike Binder,Valéria Tomori,Mónika Nyitrai, ídám Fizil, Gyula Batta
Author address:
Division of Molecular Biology, Biocenter, Innsbruck Medical University, Austria,
Department of Biochemistry,
University of Debrecen, Hungary
Full conference title:
11 th European Conference on Fungal Genetics
Abstract:
The cationic antifungal protein PAF inhibits the growth of sensitive filamentous fungi, e.g. Aspergillus nidulans,
Aspergillus fumigatus, Neursopora crassa. The plasma membrane plays a crucial role in binding PAF, regulating ion
channels in response to PAF, transmitting signals into the cell and finally also in PAF uptake. Thus the plasma
membrane might determine at least in part PAF resistance or sensitivity. A microarray8208;based gene expression
analysis in A. fumigatus revealed the deregulation of genes in response to PAF which are directly involved in fatty
acid and lipid synthesis, membrane composition and cell signalling. In accordance, the following pathways were
identified to be significantly deregulated by PAF treatment (KEGG GSEA, p<0.05): glycerophospholipid metabolism
(afm00641), inositol phosphate metabolism (afm00562) and phosphatidylinositol signalling (afm04070). A change
in the expression of genes involved in the synthesis of the plasma membrane may affect its composition and
fluidity and finally its accessibility for PAF pointing towards the attempt of the fungus to survive the antifungal
attack. We studied in more detail the interaction of PAF with the plasma membrane and found that PAF binds
exclusively to phosphoinositolphosphate (PIP), bis8208;Â (PIP2) and triphosphates (PIP3) and phosphatidic acid (PA), but
not to phospholipids. These properties were further investigated by solution NMR
15
N8208;chemical shift titration (CST)
and saturation transfer difference (STD). We could prove by CST that PAF binds to PIP3 with moderate affinity
(K=3.600/M). STD experiments revealed that PAF interacts by its aromatic parts with so far unidentified membrane
components (putatively high molecular weight proteins).
Abstract Number: PR1.53
Conference Year: 2012
Link to conference website: http://www.ecfg.info/images/Abstract_Book_Electronic.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a